Wahing, Emelyn .
HRN: 23-51-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
CO-AMOXICLAV 625MG (TAB)
08/10/2023
08/17/2023
PO
625 Mg
BID
Nsvd
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes